{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:32:51Z","timestamp":1790134371491,"version":"4.0.1"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T00:00:00Z","timestamp":1544054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["422083\/2017-8"],"award-info":[{"award-number":["422083\/2017-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Programa Estrat\u00e9gio de Apoio a Pesquisa em Sa\u00fade","award":["401761\/2015-0"],"award-info":[{"award-number":["401761\/2015-0"]}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["E-26\/203.247\/2017"],"award-info":[{"award-number":["E-26\/203.247\/2017"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006507","name":"Funda\u00e7\u00e3o Oswaldo Cruz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0006930","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T18:36:47Z","timestamp":1544121407000},"page":"e0006930","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["2'-Hydroxyflavanone activity in vitro and in vivo against wild-type and antimony-resistant Leishmania amazonensis"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2694-8249","authenticated-orcid":true,"given":"Luiza F. O.","family":"Gervazoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Gon\u00e7alves-Oz\u00f3rio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1363-3176","authenticated-orcid":true,"given":"Elmo E.","family":"Almeida-Amaral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,12,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"J Alvar","year":"2012","journal-title":"PLoS One"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1473-3099(07)70209-8","article-title":"Cutaneous leishmaniasis","volume":"7","author":"R Reithinger","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"536","DOI":"10.4269\/ajtmh.1991.44.536","article-title":"Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease","volume":"44","author":"A Barral","year":"1991","journal-title":"Am J Trop Med Hyg"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.1016\/j.ijid.2011.03.021","article-title":"Recent advances in leishmaniasis treatment","volume":"15","author":"TS Tiuman","year":"2011","journal-title":"Int J Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.3390\/ijms14023395","article-title":"Natural products as a source for treating neglected parasitic diseases","volume":"14","author":"D Ndjonka","year":"2013","journal-title":"Int J Mol Sci"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.drup.2004.07.002","article-title":"Leishmaniasis: drugs in the clinic, resistance and new developments","volume":"7","author":"M Ouellette","year":"2004","journal-title":"Drug Resist Updat"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s00436-011-2555-5","article-title":"Leishmania antimony resistance: what we know what we can learn from the field","volume":"109","author":"K Ait-Oudhia","year":"2011","journal-title":"Parasitol Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e0006310","DOI":"10.1371\/journal.pntd.0006310","article-title":"Antimony susceptibility of Leishmania isolates collected over a 30-year period","volume":"12","author":"N Eddaikra","year":"2018","journal-title":"Algeria. PLoS Negl Trop Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"571242","DOI":"10.4061\/2011\/571242","article-title":"Use of antimony in the treatment of leishmaniasis: current status and future directions","volume":"2011","author":"AK Haldar","year":"2011","journal-title":"Mol Biol Int"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1128\/AAC.01196-07","article-title":"Inhibition of ABC transporters abolishes antimony resistance in Leishmania Infection","volume":"52","author":"J Mookerjee Basu","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4103\/0255-0857.96703","article-title":"Relapse of kala-azar after use of multiple drugs: a case report and brief review of literature","volume":"30","author":"K Pandey","year":"2012","journal-title":"Indian J Med Microbiol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/2229-5070.129142","article-title":"Drug resistance in leishmaniasis: Newer developments","volume":"4","author":"S Mohapatra","year":"2014","journal-title":"Trop Parasitol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1471-4922(03)00069-2","article-title":"Pentamidine uptake and resistance in pathogenic protozoa: past, present and future","volume":"19","author":"PG Bray","year":"2003","journal-title":"Trends Parasitol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.2174\/092986712800229087","article-title":"The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases\u2014part II","volume":"19","author":"TJ Schmidt","year":"2012","journal-title":"Curr Med Chem"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bmc.2013.11.048","article-title":"Natural product based leads to fight against leishmaniasis","volume":"22","author":"N Singh","year":"2014","journal-title":"Bioorg Med Chem"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"11305","DOI":"10.1021\/cr500365f","article-title":"Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis","volume":"114","author":"AS Nagle","year":"2014","journal-title":"Chem Rev"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1104\/pp.126.2.485","article-title":"Flavonoid biosynthesis. A colorful model for genetics, biochemistry, cell biology, and biotechnology","volume":"126","author":"B Winkel-Shirley","year":"2001","journal-title":"Plant Physiol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e0004442","DOI":"10.1371\/journal.pntd.0004442","article-title":"Oral Efficacy of Apigenin against Cutaneous Leishmaniasis: Involvement of Reactive Oxygen Species and Autophagy as a Mechanism of Action","volume":"10","author":"F Fonseca-Silva","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e3093","DOI":"10.1371\/journal.pntd.0003093","article-title":"The effect of (-)-epigallocatechin 3-O\u2014gallate in vitro and in vivo in Leishmania braziliensis: involvement of reactive oxygen species as a mechanism of action","volume":"8","author":"JD Inacio","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1021\/np400193m","article-title":"Reactive oxygen species production by quercetin causes the death of Leishmania amazonensis intracellular amastigotes","volume":"76","author":"F Fonseca-Silva","year":"2013","journal-title":"J Nat Prod"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1021\/np400624d","article-title":"In vitro and in vivo effects of (-)-epigallocatechin 3-O-gallate on Leishmania amazonensis","volume":"76","author":"JD Inacio","year":"2013","journal-title":"J Nat Prod"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.exppara.2012.06.008","article-title":"Mitochondrial damage contribute to epigallocatechin-3-gallate induced death in Leishmania amazonensis","volume":"132","author":"JD Inacio","year":"2012","journal-title":"Exp Parasitol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e14666","DOI":"10.1371\/journal.pone.0014666","article-title":"Reactive oxygen species production and mitochondrial dysfunction contribute to quercetin induced death in Leishmania amazonensis","volume":"6","author":"F Fonseca-Silva","year":"2011","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.cbi.2007.02.012","article-title":"Flavanone and 2&apos;-OH flavanone inhibit metastasis of lung cancer cells via down-regulation of proteinases activities and MAPK pathway","volume":"167","author":"YC Hsiao","year":"2007","journal-title":"Chem Biol Interact"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/carcin\/bgr021","article-title":"2&apos;-hydroxyflavanone inhibits proliferation, tumor vascularization and promotes normal differentiation in VHL-mutant renal cell carcinoma","volume":"32","author":"LD Nagaprashantha","year":"2011","journal-title":"Carcinogenesis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/mnfr.201100651","article-title":"2&apos;-Hydroxyflavanone induces apoptosis through Egr-1 involving expression of Bax, p21, and NAG-1 in colon cancer cells","volume":"56","author":"SY Shin","year":"2012","journal-title":"Mol Nutr Food Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00436-010-1852-8","article-title":"Selection and phenotype characterization of potassium antimony tartrate-resistant populations of four New World Leishmania species","volume":"107","author":"DB Liarte","year":"2010","journal-title":"Parasitol Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1021\/ci300367a","article-title":"admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties","volume":"52","author":"F Cheng","year":"2012","journal-title":"J Chem Inf Model"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrd1824","article-title":"Opportunities and challenges in antiparasitic drug discovery","volume":"4","author":"R Pink","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"CA Lipinski","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"CA Lipinski","year":"2004","journal-title":"Drug Discov Today Technol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"SL Croft","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1475-9292-6-3","article-title":"Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis. Institute Pasteur, Paris. 13\u201315 June, 2006","volume":"6","author":"F Modabber","year":"2007","journal-title":"Kinetoplastid Biol Dis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e0006052","DOI":"10.1371\/journal.pntd.0006052","article-title":"Drug resistance and treatment failure in leishmaniasis: A 21st century challenge","volume":"11","author":"A Ponte-Sucre","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10886-013-0248-5","article-title":"Flavonoids: their structure, biosynthesis and role in the rhizosphere, including allelopathy","volume":"39","author":"LA Weston","year":"2013","journal-title":"J Chem Ecol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1017\/S0031182009991594","article-title":"Inhibitory effects of (-)-epigallocatechin-3-gallate from green tea on the growth of Babesia parasites","volume":"137","author":"M Aboulaila","year":"2010","journal-title":"Parasitology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.exppara.2007.04.015","article-title":"Trypanosoma cruzi: in vitro and in vivo antiproliferative effects of epigallocatechin gallate (EGCg)","volume":"117","author":"MC Guida","year":"2007","journal-title":"Exp Parasitol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1021\/acs.jnatprod.5b00011","article-title":"Effect of Apigenin on <italic>Leishmania amazonensis<\/italic> Is Associated with Reactive Oxygen Species Production Followed by Mitochondrial Dysfunction","volume":"78","author":"F Fonseca-Silva","year":"2015","journal-title":"J Nat Prod"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0166-6851(99)00110-3","article-title":"The Leishmania mexicana proteasome","volume":"103","author":"CD Robertson","year":"1999","journal-title":"Mol Biochem Parasitol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e4918","DOI":"10.1371\/journal.pone.0004918","article-title":"HIV aspartyl peptidase inhibitors interfere with cellular proliferation, ultrastructure and macrophage infection of Leishmania amazonensis","volume":"4","author":"LO Santos","year":"2009","journal-title":"PLoS One"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1086\/592280","article-title":"Intracellular survival of Leishmania species that cause visceral leishmaniasis is significantly reduced by HIV-1 protease inhibitors","volume":"198","author":"N Trudel","year":"2008","journal-title":"J Infect Dis"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0006930","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T05:28:18Z","timestamp":1589002098000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0006930"}},"subtitle":[],"editor":[{"given":"Sima","family":"Rafati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,12,6]]},"references-count":41,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0006930","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,6]]}}}